Zumrad | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

50 results for “Zumrad”

Trials

View all 29 →

Active, not recruiting

A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors

51 participants · First posted Jul 1, 2020

Active, not recruiting

A First-in-Human Study of PRL3-ZUMAB

38 participants · First posted Jun 19, 2017

Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors

14 participants · First posted Oct 8, 2019

Drugs

PRL3-zumab

SOCS-2 (AMRAD)

MRAD-P1

Organizations

Murad, LLC

United States

Zura Bio

United States

News

View all 15 →

Pfizer Withdraws EU Bladder Cancer Filing After CHMP Concerns

Spago Nanomedical Prioritizes Tumorad Program, Advances 177Lu-SN201 Clinical Study

Spago Nanomedical Advances Tumorad Program, Streamlines Operations for Clinical Development Focus

Page 1 of 5